Izotropic Corporation announced a non-brokered private placement to raise up to $150,000 by issuing 750,000 units at $0.20 each to a strategic investor. Each unit includes one common share and one warrant exercisable at $0.30 for three years. The funds will support general working capital as the company advances its IzoView breast CT imaging system, aimed at improving breast cancer screening and diagnosis. Completion depends on regulatory approvals, and securities will be subject to a hold period and U.S. securities restrictions.
Izotropic Corporation's private placement news is presented with Health-sector market data from Pluang. For readers following Health-sector stocks, 55 out of 100 priced US stocks rose while 37 fell. Notable movers include Acadia Healthcare Company Inc (ACHC) at USD 28.58 with a +2.81% change and a typical hold time of 8 days, Bio-Rad Laboratories, Inc. Class A (BIO) at USD 378.19 with a -2.41% change and 100% sell order activity, and Humana Inc (HUM) at USD 388.00 with a +2.12% change and balanced buy/sell order activity. Data is as of Sep 25, 2026 18:42 WIB.
Assured Guaranty Ltd. (NYSE: AGO) saw its stock price pressured to a new 52-week low of $68.04 despite a recent upgrade to "Buy" by Roth Capital. The company is involved in the financial restructuring of Brightline Florida, where a subsidiary insured...
Legacy Education Inc. reported Q4 2026 earnings with an EPS of $0.13, missing analyst estimates of $0.15, and revenue of $20.1 million, slightly below expectations. Despite this, the company achieved a 12% year-over-year revenue increase in Q4 and a ...
Carnival Corporation & plc is set to report Q3 earnings with analysts forecasting $8.39 billion in revenue and $1.36 EPS, reflecting a 4.9% decline from last year. The company's stock has dropped 27% recently due to a 30% surge in Brent oil prices, w...
Oklo, a pre-revenue nuclear tech company, is developing advanced small modular reactors (SMRs) called Aurora Powerhouses aimed at clean energy for data centers. UBS set a price target of $41, indicating a 7.08% upside from the current $38.29 stock pr...
Philip Morris and Altria both recently raised their dividends, but Philip Morris shows stronger growth potential with its expanding global smoke-free product line, driving revenue and earnings growth. Philip Morris targets 9%-11% annual EPS growth th...
